FDA Breakthrough Therapy Designation Positions Relay’s Zovegalisib as Potential Game-Changer for Advanced Breast Cancer
Market Chameleon (Tue, 3-Feb 7:38 AM)
Zovegalisib Shows Consistent Efficacy Across Diverse Breast Cancer Subsets—Relay Therapeutics Highlights Positive Phase 3 Momentum
Market Chameleon (Fri, 12-Dec 8:36 AM)
